A detailed history of Marotta Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Marotta Asset Management holds 1,780 shares of ABBV stock, worth $320,400. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,780
Previous 1,834 2.94%
Holding current value
$320,400
Previous $314,000 11.78%
% of portfolio
0.07%
Previous 0.06%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$163.84 - $199.33 $8,847 - $10,763
-54 Reduced 2.94%
1,780 $351,000
Q2 2024

Jul 17, 2024

BUY
$154.79 - $180.76 $11,918 - $13,918
77 Added 4.38%
1,834 $314,000
Q4 2023

Jan 03, 2024

SELL
$137.6 - $154.97 $13,072 - $14,722
-95 Reduced 5.13%
1,757 $272,000
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $33,397 - $38,662
250 Added 15.61%
1,852 $276,000
Q2 2023

Jul 05, 2023

SELL
$132.51 - $164.9 $1,192 - $1,484
-9 Reduced 0.56%
1,602 $215,000
Q4 2022

Jan 03, 2023

SELL
$138.31 - $165.87 $12,862 - $15,425
-93 Reduced 5.46%
1,611 $0
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $12,798 - $16,271
93 Added 5.77%
1,704 $260,000
Q1 2022

Apr 08, 2022

BUY
$131.98 - $163.75 $212,619 - $263,801
1,611 New
1,611 $261,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Marotta Asset Management Portfolio

Follow Marotta Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marotta Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Marotta Asset Management with notifications on news.